Innovative Medicines Initiative (IMI) Online Stakeholder Forum 2020

IMI
Innovation

The IMI Stakeholder Forum 2020 will take place online on Tuesday 10 November. The theme this year is 'Broader horizons: growing Europe’s health partnership'.

The last calls for IMI2 were launched earlier this year, and the Stakeholder Forum will take stock of what was achieved, and the many lessons learned around what has worked well. It will also explore what can be improved upon, and look forward to a new adventure being proposed under Horizon Europe.

The event will feature leaders in both policy making and science and technology expertise.

The forum will focus on paediatric cancers to demonstrate how a new partnership would bring new stakeholders together, synergise with the Cancer Mission and be more inclusive in the co-creation of ideas for the programme.  We will also want to listen to you – our stakeholders - to help develop the new partnership, avoid pitfalls and build together a world leading collaboration.

To register and view the agenda visit https://www.imi.europa.eu/news-events/events/imi-stakeholder-forum-2020

Registration is free but obligatory. The deadline for registration is 8 November 2020.

Confirmed speakers include:

  • Olivier Laureau, President, Servier group
  • Jan Kimpen, Global Chief Medical Officer, Philips
  • Mark Miller, Executive Vice-President - Chief Medical Officer, bioMerieux
  • Ruth Lydia Ladenstein, Professor of Paediatrics and Head of the Clinical Trials Unit S²IRP – CCRI, St. Anna Children’s Hospital
  • Gilles Vassal, Professor of Oncology, University Paris XI, Gustave Roussy Comprehensive Cancer Center
  • Annette Bakker, President, Children's Tumor Foundation
  • Salah-Dine Chibout, Global Head of Discovery and Investigational Safety, Novartis
  • Elena Annoni, Global Reimbursement & Health Economics Director, Medtronic Surgical Technologies

Documents

Registration

Event Information

10-11-2020 | 08:15-11:40

Venue Location